These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 3308390

  • 1. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N, Ravic M, Bizière K.
    Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
    [Abstract] [Full Text] [Related]

  • 2. Minaprine and dose response in depression. An investigation of two fixed doses of minaprine compared with imipramine.
    Montgomery SA, Baldwin DS, Priest RG, Steinert J, Patel A, Herrington RN, Livingston HM.
    Pharmacopsychiatry; 1991 Sep; 24(5):168-74. PubMed ID: 1775522
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression.
    Amsterdam JD, Dunner DL, Fabre LF, Kiev A, Rush AJ, Goodman LI.
    Pharmacopsychiatry; 1989 Jul; 22(4):137-43. PubMed ID: 2668978
    [Abstract] [Full Text] [Related]

  • 4. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
    Hebenstreit GF, Fellerer K, Fichte K, Fischer G, Geyer N, Meya U, Sastre-y-Hernández M, Schöny W, Schratzer M, Soukop W.
    Pharmacopsychiatry; 1989 Jul; 22(4):156-60. PubMed ID: 2668980
    [Abstract] [Full Text] [Related]

  • 5. Multicentric double-blind study comparing efficacy and safety of minaprine and imipramine in dysthymic disorders.
    Salzmann E, Robin JL.
    Neuropsychobiology; 1995 Jul; 31(2):68-75. PubMed ID: 7760988
    [Abstract] [Full Text] [Related]

  • 6. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
    Feiger AD.
    Psychopharmacol Bull; 1996 Jul; 32(4):659-65. PubMed ID: 8993088
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind study.
    Suominen J, Tamminen T, Elosuo R, Manniche PM.
    Pharmacopsychiatry; 1988 Sep; 21(5):238-44. PubMed ID: 3067246
    [Abstract] [Full Text] [Related]

  • 8. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E, Feighner J, Mandos LA, Rickels K.
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [Abstract] [Full Text] [Related]

  • 9. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB, Crowder JE, Wilcox CS, Ryan PJ.
    Psychopharmacol Bull; 1990 Mar; 26(2):185-9. PubMed ID: 2146697
    [Abstract] [Full Text] [Related]

  • 10. Platelet 3H-imipramine binding and response to minaprine in patients with major depression.
    Maj M, Mastronardi P, Palomba U, Romano M, Ventra C, Kemali D.
    Pharmacopsychiatry; 1988 Mar; 21(2):101-3. PubMed ID: 3393597
    [Abstract] [Full Text] [Related]

  • 11. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM.
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [Abstract] [Full Text] [Related]

  • 12. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD.
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [Abstract] [Full Text] [Related]

  • 13. [Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients].
    Olié JP, Galinowski A, Lehert P, Lemonnier F, Lôo H.
    Encephale; 1993 Apr; 19(4):333-40. PubMed ID: 8275921
    [Abstract] [Full Text] [Related]

  • 14. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [Abstract] [Full Text] [Related]

  • 15. Nefazodone: aspects of efficacy.
    Rickels K, Robinson DS, Schweizer E, Marcus RN, Roberts DL.
    J Clin Psychiatry; 1995 Feb; 56 Suppl 6():43-6. PubMed ID: 7649973
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10.
    Vorbach EU, Arnoldt KH, Hübner WD.
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():81-5. PubMed ID: 9342765
    [Abstract] [Full Text] [Related]

  • 17. A double-blind study of minaprine versus amitriptyline in major depression.
    Del Zompo M, Bernardi F, Burrai C, Bocchetta A.
    Neuropsychobiology; 1997 Sep; 24(2):79-83. PubMed ID: 2134115
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS, Kobak KA, Jefferson JW, Mazza J, Greist JH.
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [Abstract] [Full Text] [Related]

  • 19. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G, Saxena BM, Nair NP, Kutcher SP, Bakish D, Bradwejn J, Kennedy SH, Sharma V, Remick RA, Kukha-Mohamad SA.
    Clin Neuropharmacol; 1993 May; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.